Thursday's session: gap up and gap down stock in the S&P500 index
By Mill Chart
Last update: May 16, 2024
What's going on in today's session: S&P500 gap up and gap down stocks
Today's top gap down stocks
| Ticker | Change | Comment |
|---|---|---|
| CRL | -3.62% | CHARLES RIVER LABORATORIES's (NYSE:CRL) shares suffered a 3.62% decline to $224.15 during Thursday's session, accompanied by a 6.59% gap. Shareholders saw the stock price going 23.02% higher is the past 6 months. |
| DE | -3.35% | Unfortunate news for DEERE & CO's (NYSE:DE) stock! It registered a 3.35% decline to $400.17 in today's session, accompanied by a 4.42% gap. The company's earnings where released Yesterday. |
| MLM | -3.33% | MARTIN MARIETTA MATERIALS's (NYSE:MLM) shares experienced a 3.33% decline to $592.25 during Thursday's session, accompanied by a 4.06% gap. In the last 6 months the share price increased with 32.6%. |
| BIIB | -2.57% | In today's session, BIOGEN INC's (NASDAQ:BIIB) stock price decreased by 2.57% to $229.28, exhibiting a 3.32% gap. A press release (Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis) was released earlier today. |
| URI | -2.48% | UNITED RENTALS INC's (NYSE:URI) shares experienced a 2.48% decline to $694.68 during Thursday's session, accompanied by a 3.81% gap. Shareholders saw the stock price going 48.11% higher is the past 6 months. |
| VMC | -2.42% | Today, VULCAN MATERIALS CO's (NYSE:VMC) stock experienced a 2.42% fall to $263.96 with a 2.91% gap. In the last 6 months the share price increased with 27.38%. |
| SWK | -2.11% | STANLEY BLACK & DECKER INC's (NYSE:SWK) stock price is declining with 2.11% to a price of $89.46 with a gap of 4.24%. |
| AMGN | -2.11% | AMGEN INC's (NASDAQ:AMGN) shares fell 2.11% to $312.31 during Thursday's session with a gap of 3.32%. The stock is trading 20.82% higher than a month ago. |
| TFX | -2.09% | TELEFLEX INC's (NYSE:TFX) shares fell 2.09% to $215.2 during Thursday's session with a gap of 3.61%. |
| POOL | -2.09% | POOL CORP's (NASDAQ:POOL) shares declined by 2.09% to $375.08, showing a 3.03% gap in today's session. |
For the full top loser list go to our gap down stocks screener.
AMGEN INC
NASDAQ:AMGN (5/31/2024, 7:23:04 PM)
After market: 305.7 -0.15 (-0.05%)305.85
+4.85 (+1.61%)
AMGN News
a day ago - InvezzShould you buy Amgen’s stock above $300?Amgen Inc. (NASDAQ:AMGN) has recently been in the news due to its involvement in the promising obesity drug market. Analysts project significant growth in this sector, with Amgen among key players like Novo Nordisk and Eli Lilly. The U.S. FDA has approved Amgen’s Bkemv, the first interchangeable biosimilar for Soliris. This approval is a milestone, […]
3 days ago - The Motley FoolWhere Will Amgen Be in 3 Years?The Amgen of 2027 could be much be larger than some investors expect.
4 days ago - InvestorPlaceOZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETFAs weight loss drugs are gaining popularity Roundhill GLP 1 And Weight Loss ETF (OZEM) has launched as anew way to invest in them.
4 days ago - Market News VideoDow Movers: AMGN, AAPL
4 days ago - AmgenAMGEN TO PRESENT INNOVATIVE RESEARCH FROM ITS ROBUST ONCOLOGY PORTFOLIO AT ASCO 2024/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the presentation of new data from its broad oncology portfolio at the American Society of Clinical Oncology...
6 days ago - The Motley FoolAmgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?The gold rush for obesity medications just got a bit more intense.
8 days ago - USA News GroupEmerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More/PRNewswire/ -- USA News Group News Commentary – As the 2024 American Society of Clinical Oncology (ASCO) annual meeting approaches, excitement builds over the...
8 days ago - InvestorPlaceStocks to Buy: 7 Undeniable Dow Darlings to Pile Into NowMost Dow stocks are strong investments but these 7 stand out at the moment as the macroenvironment trends positive again.
11 days ago - InvestorPlace7 Reliable Blue-Chip Stocks That Cannot MissThese reliable blue-chip stocks to own are the closest thing to slam dunk investments that exist. Discover why you should buy them now.
12 days ago - InvestorPlace7 Biotech Stocks That Could Breathe New Life Into Your PortfolioThanks to the underlying pertinence, these established biotech stocks to buy offer confidence to investors facing tricky market conditions.
13 days ago - AmgenNEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE® TO HELP PATIENTS LIVING WITH COPD/PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people...
13 days ago - The Motley FoolIs Amgen a Threat to Eli Lilly in This Billion-Dollar Market?Eli Lilly's biggest growth drivers today are its weight loss drugs.
